Across four decades, Propath’s GLP and GCP compliant facility in the UK has successfully collaborated on studies with biopharmaceutical companies, large and small, across the world.
Today we are recognised as a leading specialist in spatial biology, molecular pathology and histopathology, collaborating with clients across the globe to advance their clinical and pre-clinical programmes.
The quality of our service is rooted in the expertise and professionalism of our brilliant scientists and technicians – who bring a rich blend of insight, thoroughness and experience to every study we undertake – from routine histology and immunohistochemistry to advanced spatial transcriptomics and ultra-high plex IHC.
Thousands of successfully conducted studies have demonstrated our professionalism and our commitment to clients. And our vision to keep investing for the future – in our people and our technology – will ensure we continue to provide a service that is as responsive, innovative and dependable as our clients require.
As the UK’s most prestigious accolade for companies, Propath was selected to receive the Queen's Award in recognition of its exceptional contribution to the Global Life Sciences sector across the last four decades.
The award reflects the collective efforts over many years of our highly committed scientists and technicians, working collaboratively to support our clients’ research.
We are specialists in molecular pathology and histopathology for biopharma R&D. It’s what we’ve been doing for over thirty years. Trusted by our clients – small and large – across the world.
